Posner Christopher
CIK 0001748265
President and CEODirector
Filings
16
Latest Mar 4, 2025
Issuers covered
1
Showing
16 of 16
Page 1
Track record
8 of 14 open-market trades scored (57% price coverage) - 6 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 8 | 50% | -18.5% | -2.3% | +11.9% | -82.7% |
| 90 days | 8 | 38% | -26.1% | -35.9% | +54.9% | -108.2% |
| 180 days | 8 | 50% | -22.6% | +8.2% | +65.4% | -164.4% |
| 365 days | 8 | 88% | +25.5% | +40.6% | +73.8% | -105.0% |
Issuers
Companies where Posner Christopher has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CARA | Cara Therapeutics, Inc. | 16 | Mar 4, 2025 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|